SF Holding(SZ:002352) Zhong Guo Zheng Quan Bao·2026-01-18 14:20Core Insights - Institutional enthusiasm for researching listed companies remains high, with 316 companies disclosing investor research records this year [1][2] - The brain-computer interface sector has seen increased attention from institutional investors, with companies like Xiangyu Medical and Aipeng Medical leading in research inquiries [11][12] Group 1: Institutional Research Activity - A total of 316 listed companies have disclosed institutional investor research records this year, with Xiangyu Medical receiving the highest number of inquiries at 208 [2][3] - Other companies with significant institutional interest include Haitan Ruisheng (207 inquiries), Aipeng Medical (142 inquiries), and Shiji Technology (132 inquiries) [3] - Notably, multiple prominent funds have shown concentrated interest in SF Holding, with 35 institutions conducting research on the company [5][6] Group 2: SF Holding and Strategic Partnerships - SF Holding and Jitu Express announced a strategic mutual shareholding agreement on January 15, with an investment transaction amounting to HKD 8.3 billion [9] - The partnership aims to enhance operational synergies, utilizing SF's delivery network in domestic markets and Jitu's established networks in international markets like the Philippines and Saudi Arabia [8] - SF Holding's stock price was reported at CNY 38.81 per share, with a market capitalization of CNY 194.1 billion as of January 16 [10] Group 3: Brain-Computer Interface Developments - Xiangyu Medical plans to upgrade 27 core products by June 2026, integrating brain-computer interface technology to transform passive rehabilitation devices into active ones [11] - Aipeng Medical is focusing on exploring brain-computer interface investments aligned with its strategic direction, emphasizing research in sensors, electrodes, and clinical applications for mental health disorders [12]